The European Commission has approved vaccines adapted to omicrons from Pfizer and Moderna

The European Commission has approved vaccines adapted to omicrons from Pfizer and Moderna
The European Commission has approved vaccines adapted to omicrons from Pfizer and Moderna

The European Commission has (on Thursday) approved the first two booster vaccines against covid-19 from the companies BioNTech-Pfizer and Moderna, which are designed against variants, based on the positive opinions of the EMA, Kyriakidesov said, adding that the approval of other vaccines should follow soon.

.@EU_Commission yesterday authorized the first two variant-adapted COVID-19 booster vaccines from BioNTech-Pfizer and Moderna following positive opinions from @EMA_News.

More authorizations should be coming soon, starting the rollout in our Member States vaccination campaigns. https://t.co/SVHfDuhWZo

2. of 2022 at 8:26 pspvek archived: 2. of 2022 at 11:32

The modified vaccines are changed to both the original virus variant and the omicron BA.1 variant. The European Medicines Agency (EMA) is currently working on a vaccine based on the submutations of the BA.4 and BA.5 micron variant coronaviruses, which are now dominant and virulent. According to the World Health Organization (WHO), it is now the BA.5 subvariant and accounts for 80 percent of covid-19 cases worldwide.

The EU regulator has recommended booster shots for people aged 12 and over who have completed at least a basic vaccination against the covid-19 disease in the past.

Vaccine company Pfizer/BioNTech and Moderna, which are members of the coronavirus variant omicron, have been approved by the US Food and Drug Administration (FDA) in the center. In mid-August, the modified window frame from the company Moderna was also approved by the British Lkov ad MHRA.

The EC calls for a message of transparency

In addition to the announcements on new holiday packages, the European Commission also came up with a set of recommendations for EU countries to help prevent pandemic waves.

According to the EC, the main goal should be to increase the rate of vaccination, especially among groups for whom covid-19 is a threat, and in countries that are still lagging behind in the EU. In this regard, the Commission proposes to combine the vaccination campaign with the measles vaccination and calls for clear communication to the public regarding the transfer of vaccinations.

In the European Union, almost 73 percent of the population has so far completed the basic vaccination regime against covid-19, and more than half of the population has taken the first strengthening vacation tax, however, there are known differences between individual states. While in Italy 70 percent of the population received the first booster dog, in Estonia it is about 40 percent and in Romania and Bulgaria only about ten percent of the population.

According to the EC, depending on the development of the epidemic situation, governments must be prepared to look for non-pharmaceutical interventions, among which are mandatory respiratory tract infections and restrictions on mass events. The Union executive stupidly points out the risk of long-term sweats, which many patients suffer after a prolonged period of covid-19, even with a relatively minor acute phase of the disease. Evidence is emerging that one in eight people who contract covid-19 will develop crippling symptoms that last much longer than expected, the commission said.

Many EU countries have already seen a certain increase in the number of infections with the coronavirus in recent years, but in recent weeks they have seen a sharp decrease. Europe does not currently record more orders than at the end of the year. The European Commission declared the current situation to be worrying.


The article is in Czech

Tags: European Commission approved vaccines adapted omicrons Pfizer Moderna

PREV The influencer gave birth to a baby boy Dion – eXtra.cz
NEXT US Open | A winning point to total American silence. The Czechs ended the big dream of the Williams sisters